Efficacy of second-generation antipsychotics in patients at ultra-high risk and those with first-episode or multi-episode schizophrenia

References

• YungARYuenHPMcGorryPDMapping the onset of psychosis: the Comprehensive Assessment of At-Risk Mental StatesAust N Z J Psychiatry20053911–1296497116343296
   PubMed Web of Science ®Google Scholar
• PhillipsLJYungARMcGorryPDIdentification of young people at risk of psychosis: validation of Personal Assessment and Crisis Evaluation Clinic intake criteriaAust N Z J Psychiatry200034SupplS164S16911129303
   PubMed Web of Science ®Google Scholar
• YungARMcGorryPDMcFarlaneCAJacksonHJPattonGCRakkarAMonitoring and care of young people at incipient risk of psychosisSchizophr Bull19962222833038782287
   PubMed Web of Science ®Google Scholar
• MarshallMLewisSLockwoodADrakeRJonesPCroudaceTAssociation between duration of untreated psychosis and outcome in cohorts of first-episode patients: a systematic reviewArch Gen Psychiatry20056297598316143729
   PubMed Web of Science ®Google Scholar
• PerkinsDOGuHBotevaKLiebermanJARelationship between duration of untreated psychosis and outcome in first-episode schizophrenia: a critical review and meta-analysisAm J Psychiatry2005162101785180416199825
   PubMed Web of Science ®Google Scholar
• McGlashanTHWalshBCWoodsSWThe Psychosis-Risk Syndrome Handbook for Diagnosis and Follow-upNew York, NYOxford University Press2010
   Google Scholar
• KlosterkötterJSchultze-LutterFBechdolfARuhrmannSPrediction and prevention of schizophrenia: what has been achieved and where to go next?World Psychiatry201110316517421991266
   PubMed Web of Science ®Google Scholar
• International Early Psychosis Association Writing GroupInternational clinical practice guidelines for early psychosisBr J Psychiatry Suppl200548s120s12416055801
   PubMedGoogle Scholar
• McGlashanTHZipurskyRBPerkinsDRandomized, double-blind trial of olanzapine versus placebo in patients prodromally symptomatic for psychosisAm J Psychiatry2006163579079916648318
   PubMed Web of Science ®Google Scholar
• WalkerEFCornblattBAAddingtonJThe relation of antipsychotic and antidepressant medication with baseline symptoms and symptom progression: a naturalistic study of the North American Prodrome Longitudinal SampleSchizophr Res20091151505719709859
   PubMed Web of Science ®Google Scholar
• McGorryPDYungARPhillipsLJRandomized controlled trial of interventions designed to reduce the risk of progression to first-episode psychosis in a clinical sample with subthreshold symptomsArch Gen Psychiatry2002591092192812365879
   PubMed Web of Science ®Google Scholar
• RuhrmannSBechdolfAKühnKULIPS study groupAcute effects of treatment for prodromal symptoms for people putatively in a late initial prodromal state of psychosisBr J Psychiatry Suppl200751s88s9518055944
   PubMedGoogle Scholar
• WoodsSWBreierAZipurskyRBRandomized trial of olanzapine versus placebo in the symptomatic acute treatment of the schizophrenic prodromeBiol Psychiatry2003544453464 Erratum in: Biol Psychiatry. 2003;54(4):49712915290
   PubMed Web of Science ®Google Scholar
• WoodsSWTullyEMWalshBCAripiprazole in the treatment of the psychosis prodrome: an open-label pilot studyBr J Psychiatry Suppl200751s96s10118055946
   PubMedGoogle Scholar
• HarounNDunnLHarounACadenheadKSRisk and protection in prodromal schizophrenia: ethical implications for clinical practice and future researchSchizophr Bull200632116617816207892
   PubMed Web of Science ®Google Scholar
• The ICD-10 Classification of Mental and Behavioural Disorders: Diagnostic Criteria for ResearchGenevaWorld Health Organization1993
   Google Scholar
• KaySRFiszbeinAOplerLAThe positive and negative syndrome scale (PANSS) for schizophreniaSchizophr Bull19871322612763616518
   PubMed Web of Science ®Google Scholar
• National Institute of Mental healthCGI: Clinical global impressionGuyWBonatoRRManual for the ECDEU Assessment Battery2nd edBethesda, MDUS Department of Health, Education, and Welfare, National Institute of Mental Health1970
   Google Scholar
• EndicottJSpitzerRLFleissJLThe global assessment scale. A procedure for measuring overall severity of psychiatric disturbanceArch Gen Psychiatry1976336766771938196
   PubMed Web of Science ®Google Scholar
• SimpsonGMAngusJWA rating scale for extrapyramidal side effectsActa Psychiatr Scand Suppl197021211194917967
   PubMedGoogle Scholar
• BarnesTRA rating scale for drug-induced akathisiaBr J Psychiatry19891546726762574607
   PubMed Web of Science ®Google Scholar
• MunetzMRBenjaminSHow to examine patients using the Abnormal Involuntary Movement ScaleHosp Community Psychiatry19883911117211772906320
   PubMedGoogle Scholar
• LiebermanJAKoreenARChakosMFactors influencing treatment response and outcome of first-episode schizophrenia: implications for understanding the pathophysiology of schizophreniaJ Clin Psychiatry199657Suppl 9598823344
   PubMed Web of Science ®Google Scholar
• BuchananRWKreyenbuhlJKellyDLSchizophrenia Patient Outcomes Research Team (PORT)The 2009 schizophrenia PORT psychopharmacological treatment recommendations and summary statementsSchizophr Bull2010361719319955390
   PubMed Web of Science ®Google Scholar
• ChatterjeeAChakosMKoreenAPrevalence and clinical correlates of extrapyramidal signs and spontaneous dyskinesia in never-medicated schizophrenic patientsAm J Psychiatry199515212172417298526237
   PubMed Web of Science ®Google Scholar
• LiebermanJASheitmanBChakosMRobinsonDSchoolerNKeithSThe development of treatment resistance in patients with schizophrenia: a clinical and pathophysiologic perspectiveJ Clin Psychopharmacol1998182 Suppl 120S24S9555612
   PubMed Web of Science ®Google Scholar
• McEvoyJPHogartyGESteingardSOptimal dose of neuroleptic in acute schizophrenia. A controlled study of the neuroleptic threshold and higher haloperidol doseArch Gen Psychiatry19914887397451883257
   PubMed Web of Science ®Google Scholar
• RobinsonDGWoernerMGAlvirJMPredictors of treatment response from a first episode of schizophrenia or schizoaffective disorderAm J Psychiatry1999156454454910200732
   PubMed Web of Science ®Google Scholar
• ScherkHPajonkFGLeuchtSSecond-generation antipsychotic agents in the treatment of acute mania: a systematic review and meta-analysis of randomized controlled trialsArch Gen Psychiatry2007644:442455 Review17404121
   PubMed Web of Science ®Google Scholar
• KaneJMLeuchtSCarpenterDDochertyJPExpert Consensus Panel for Optimizing Pharmacologic Treatment of Psychotic DisordersThe expert consensus guideline series. Optimizing pharmacologic treatment of psychotic disorders. Introduction: methods, commentary, and summaryJ Clin Psychiatry200364Suppl 1251914640142
   PubMed Web of Science ®Google Scholar